Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...
A team led by Professor Kazuhiro Maeshima of the National Institute of Genetics (ROIS) and SOKENDAI in Japan has developed a ...
We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...
We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...
The Global DNA Data Storage Market Size is projected to grow at a CAGR of 74.48% from 2026 to 2032, according to a new report published by Verified Market Research®. The report reveals that the market ...
Airna will use the Series B round to launch a Phase 1/2 trial of its lead program for alpha-1 antitrypsin deficiency, a ...
AIRNA, a transatlantic RNA editing biotech, is prepping to launch its lead asset into clinical trials with fuel from a $155 ...
Gene editing involves precisely cutting DNA, allowing the cell to repair itself. While it has been used to treat genetic ...
Roughly one out of three women ages 14-49 in the United States develop a vaginal bacterial imbalance known as bacterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback